sales supports functions. In addition, Oriflame relocated
other operations—group finance has moved from
Waterloo, Belgium to Fribourg, Switzerland, and quality
assurance and skin research, which had been in Dublin,
Ireland, is now handled from Stockholm.
Product wise, skin care sales rose 14% with units up
13% in 2008. Color cosmetics units were up 15% and sales
increased 17%, due in part to the success of Wonderlash
mascara, which rose a whopping 130% to become
Oriflame’s No.1 selling product. Fragrance sales rose an
impressive 30% with units up 19%. Personal and hair care
was the company’s second fastest growing category in
2008, posting 23% and 21% increases in sales and units,
respectively. Oriflame’s oral care brand Optifresh posted
another year of double-digit growth as well.
R&D expenses rose 20% (to approximately $16.9 million) in 2008 and the company established a skin research
center in Stockholm.
Sales: $1.5 billion
tapped RL Public Relations for a one-year contract focused
on this consumer group.
On the product development front, Clarins describes High
Definition Body Lift as the newest and most innovative cellulite control treatment it has ever produced (or seen on the
market). The primary ingredient—blue button flower—helps
to optimize the release of excess fluids around fat cells,
thereby helping the overall formula to work more effectively
including increasing the penetration of caffeine, also known
for its fluid reducing capabilities.
In anti-aging, Clarins’ new Multi-Active Day helps correct
the appearance of early wrinkles, combats new signs of aging
and delivers high antioxidant protection all day long through
a “time-release” system. The formulation also includes two
key ingredients—soothing ambiaty and protective hesperidin—which work in tandem to reduce the appearance of
wrinkles by targeting the dermal-epidermal junction, which
is where sagging starts to appear.
Sales: $1.43 billion
Key Personnel: Christian Courtin-Clarins, Clarins Group
supervisory board chairman; Dr. Olivier Courtin-Clarins,
managing director for the Clarins Group; Philip Shearer,
chief executive officer of the Clarins Group; Lionel de
Benetti, managing director of Clarins’ laboratories and
logistics; Pierre Millet, managing director member of management board; Isabelle Herbreteau, president of the
Clarins brand; Joel Palix, president, Clarins Fragrance
Major Products: Skin care, fine fragrance, color cosmetics
and sun care products.
New Products: High Definition Body Lift, Bright Plus HP
Intensive Brightening Botanical System, Multi-Active Day.
; It’s all in the family for Clarins these days, since the
Courtins-Clarins clan last June took the cosmetics company private.
One of the firm’s goals is to grow its U.S. operations. To
that end, Clarins plans to open new skin care spas in department stores as part of its effort to bolster its U.S. presence.
In addition, the company will be courting Hispanic/Spanish-speaking consumers in the U.S., having early this year
Key Personnel: Marc Puig, chairman and chief executive
officer; Manuel Puig, vice-chairman; Jose Manuel Albesa,
chief brand officer; Javier Bach, chief operating officer;
Eulalia Alfonso, chief human resources and legal officer;
Joan Albiol, chief financial officer
Major Products: Fragrances—Paco Rabanne, Carolina
Herrera, Prada, Adolfo Dominquez, Antionio Banderas;
Cosmetics and personal care—Payor, Unica, Vitesses,
Payot, Única, Vitesse, Heno de Pravia, Lactovit, Maja,
New Products: Prada Infusion de Fleur d’Oranger, Comme
de Garcons Silver Words limited edition fragrance,
Carolina Herrera 212 on Ice limited edition scents,
Antionio Banders Seduction in Black.
; Puig’s sales in 2008 rose an impressive 8.5% over 2007
results. Cosmetics, fragrances and personal care sales
were $1.43 billion and corporate sales were $1.5 billion.
Fragrances accounted for 81% of net revenues while
cosmetics and personal care accounted for 13%. The rest
of the company’s net sales come from its fashion group. In
addition, based on the strong growth, Puig went from hav-